Northwestern Mutual Wealth Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AIM
FCM
VPM
AVM
VCM
NAMA
Northwestern Mutual Wealth Management's BEAM Position: Q1 2026 in Review
Northwestern Mutual Wealth Management opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 85 shares worth $2.03K. The stake represents ﹤0.01% of the portfolio and ranks #3594 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in BEAM as recently as Q3 2024.
Northwestern Mutual Wealth Management first reported a position in BEAM in Q4 2021 and has held it in 4 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.
- Northwestern Mutual Wealth Management held 85 shares of Beam Therapeutics worth $2.03K as of Q1 2026.
- Beam Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
- Beam Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3594 holding.
- Northwestern Mutual Wealth Management first reported a position in Beam Therapeutics in Q4 2021 and has held it in 4 quarters since.
- 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.